Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS (TSXV:ADK) finalizing CARA-STROKE application

John Ballem  March 9, 2021

DIAGNOS, following a successful Proof-of-Concept (POC) pilot study, is finalising its new application CARA-STROKE to address Stroke prevention and management, a market estimated at $36 Billion

GlobeNewswire March 9, 2021

DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology

GlobeNewswire March 4, 2021

DIAGNOS Announces Stock Options Grants

GlobeNewswire March 3, 2021

DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update

GlobeNewswire February 26, 2021

Diagnos Inc. (TSXV:ADK) announces exclusive partnership with Labtician Ophthalmics

John Ballem  February 24, 2021

DIAGNOS Announces its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabetic and Hypertensive Patients

GlobeNewswire February 24, 2021

DIAGNOS Announces Further Deployment of its AI based CARA Technology in Saudi Arabia

GlobeNewswire February 2, 2021

DIAGNOS (TSXV:ADK) announces re-opening of its medical testing in Panama

Simon Druker  January 28, 2021

DIAGNOS announces the re-opening of its medical testing in Panama

GlobeNewswire January 28, 2021

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit

GlobeNewswire January 21, 2021

Diagnos (TSXV:ADK) successfully completes ISO 13485 / MDSAP audit

Brieanna McCutcheon  January 21, 2021

DIAGNOS (TSXV:ADK) announces three-year AI partnership with University of Montreal hospital

Simon Druker  January 19, 2021

DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence

GlobeNewswire January 19, 2021

Diagnos (TSXV:ADK) forms overseas partnership to help diabetic patients

Brieanna McCutcheon  January 14, 2021

DIAGNOS Announces Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patients

GlobeNewswire January 14, 2021

DIAGNOS Provides Market Activity Update

GlobeNewswire January 5, 2021

DIAGNOS Announces the Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al-Mutairi for his Assignment as Secretary General of the Council of Private Associations of the Kingdom

GlobeNewswire November 12, 2020

9071-8776 Quebec Inc. Acquires Further Interest in DIAGNOS Inc.

GlobeNewswire November 5, 2020

DIAGNOS Announces Stock Warrants Term Extension

GlobeNewswire October 7, 2020